Table 4 Comparison of DHEAS levels between different groups of COVID-19 patients with and without heart disease and healthy participants (control).
DHEAS (µg/dL) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean ± SD | Median | Q1 | Q3 | p.value1 | p.value2 | p.value3 | p.value4 | |||
1 | HD Positive/ Patient | 84 | 71.95 ± 70.61 | 47.50 | 15.90 | 95.25 | |||||
2 | HD Negative / Patient | 517 | 106.19 ± 88.42 | 82.60 | 41.00 | 143.00 | 0.001 | ||||
3 | HD Negative / Control | 71 | 116.73 ± 99.84 | 87.00 | 48.20 | 165.00 | 0.002 | 0.342 | |||
1 | HD Positive / Inpatient | 71 | 71.78 ± 71.85 | 47.20 | 15.00 | 92.60 | |||||
2 | HD Positive / Outpatient | 13 | 72.85 ± 66.12 | 62.10 | 19.10 | 107.00 | 0.967 | ||||
3 | HD Negative / Inpatient | 278 | 85.95 ± 75.72 | 64.80 | 31.50 | 115.00 | 0.214 | 0.590 | |||
4 | HD Negative / Outpatient | 239 | 129.72 ± 96.15 | 107.00 | 60.20 | 178.00 | < 0.001 | 0.020 | < 0.001 | ||
5 | HD Negative / Control | 71 | 116.73 ± 99.84 | 87.00 | 48.20 | 165.00 | 0.002 | 0.090 | 0.007 | 0.262 | |
1 | HD Positive / patient | Female | 37 | 56.97 ± 66.57 | 22.30 | 15.00 | 66.40 | ||||
Male | 47 | 83.74 ± 72.16 | 65.00 | 33.50 | 104.00 | 0.085 | |||||
2 | HD Negative / patient | Female | 218 | 79.69 ± 71.53 | 63.05 | 28.70 | 112.00 | ||||
Male | 299 | 125.50 ± 94.47 | 104.00 | 53.00 | 172.00 | < 0.001 | |||||
3 | HD Negative / control | Female | 28 | 69.89 ± 50.43 | 59.55 | 24.80 | 91.65 | ||||
Male | 43 | 147.23 ± 112.09 | 107.00 | 54.80 | 222.00 | 0.001 | |||||
